Pharma API Polymyxin-B/ Polymyxin B for Anti-Inflammatory CAS No.: 1405-20-5

• Transport Package: 25kg/Drum
• Specification: 99%min
• Trademark: hanways
• Origin: China
• Model NO.: HANWEISHI
• Production Capacity: 500kg/Month

Product Description

Pharma API Polymyxin-B/ Polymyxin B for Anti-Inflammatory CAS NO.:1405-20-5


PRODUCT DETALS

 

Items	Specifications		Result
Appearance	White or almost white powder,hygroscopic.		Conforms
Solubility	Soluble in water.slightly soluble in alcohol.		Conforms
ldentification	A:The retention times of the major peaks from thesample solution correspond to 'those of thestandard solution,as obtained in the test forcomposition of Polymyxins. B: To the sample solution add 5ml of 2.5N sodiumhydroxide,and mix,Add 5 drops of 10mg/ml ofcupric sulfate shaking after the addition of eachdrop,A reddish-violet color is produced. C: lt gives reaction of sulphate.		Conforms
PH	5.0-7.5		5.4
Loss on drying	NMT7.0%		3.0%
Residue on ignition	NMT5.0%		0.20%
On the dried basis	Not less than 6000IU/mg		8254IU/mg
Related substances	Any impurity	NMT3.0%	1.8%
	Total impurity	17.0%	4.1%
Compositionof Polymyxins	B3	NMT6.0%	1.4%
	B1-1	NMT15.0%	8.1%
	Sum of B1,B2,B3 and B1-l	NMT80.0%	94.0%
Conlusion	The results conform to the standard of USP43

 

 

THERAPEUTIC INDICATIONS

The drug for the treatment of hair loss dwindled.
Finasteride is used to treat symptoms of BPH such as frequent and difficult urination and may reduce the chance of acute urinary retention (sudden inability to urinate). It also may decrease the chance that prostate surgery will be needed.

SHIPPING DETAILS
 

MOQ	50G
BY air	Any airport in china
By sea	Any seaport in china
By courier	/

ABOUT US 
HANWEISHI PHARMCHEM CO., LTD. is an import and export company located in Wuhan, which providing comprehensive supply solution for our customers in pharmaceutical and nutraceutical industries. We supply APIs, pharmaceutical intermediates, excipients, natural extracts, and food and feed additives. Our service also includes conducting manufacture audit, applying for regulatory registration, and contract manufacturing.
Since established in 2007, Hanways has developed long term strategic relationships with major manufacturers in China, including Zhejiang Xianju Pharmaceutical Co., Ltd, Zhejiang Guobang Pharmaceutical Co., Ltd and more than 100 others.
HANWEISHI is actively exploring the international market, as well as participating the world CPhI. Nowadays we already have a large number of customers in Southeast Asia, Mid-East, Central and South America, East Europe and African countries.